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Abstract
Summary
During the post-natal development, GFAP-expressing cells in the parenchyma progressively lose their neural stem cell (NSC)
potential, whereas this peculiar attribute is preserved in GFAP-expressing cells of adult germinal zones. Although the relationship
between astrocytes localized in the parenchyma and those in the germinal zones is elusive, many reports suggest that
GFAP-expressing cells contained in germinal zones are maintained in immature developmental stage. Starting from the observation
that the pan-astrocytic marker S100B is not expressed in the GFAP-expressing cells of adult germinal zones, we first investigated the
relationship between S100B expression and the developmental status of these astrocytic cells. We demonstrated that long after the loss
of RC2 and gain of GFAP, the onset of S100B expression characterizes a mature developmental stage in mouse telencephalic
GFAP-expressing cells, both  and . Using a transgenic -EGFP mouse-derived culture model, we next demonstratein vitro in vivo s100b
that , S100B expression in GFAP-expressing cells coincides with the loss of their NSC potential. Through a series of ectopicin vitro
and orthotopic grafting experiments, we found that in the adult subventricular zone, S100B expression is controlled by environmental
cues. Furthermore, we showed that treatment with epidermal growth factor represses S100B expression in GFAP-expressing cells in
 as well as in mouse forebrain. Altogether, our results indicate that the S100B expression defines a late developmental stage aftervitro
which GFAP-expressing cells lose their NSC potential.
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Introduction
In the adult mammalian forebrain, neurogenesis is thought to persist throughout life in only two zones: the subventricular zone (SVZ)
of the lateral ventricular wall, and the subgranular layer (SGL) of the dentate gyrus of the hippocampus (Alvarez-Buylla and
; ). The new neurons derive from adult neural stem cells (NSCs) (Gage, 2000). NSCs are capableGarcia-Verdugo, 2002 Palmer et al., 1999
of multilineage differentiation and unlimited self-renewal and have been considered as undifferentiated cells. However, this view has
recently been challenged by the finding that, in the adult mammalian forebrain, the NSCs may also have phenotypical and ultrastructural
characteristics of mature astrocytes including the presence of a light cytoplasm, gap junctions, glycogen granules and the intermediate
filament glial fibrillary acidic protein (GFAP) ( ; ; ; ; Ahn and Joyner, 2005 Doetsch et al., 1999 Filippov et al., 2003 Garcia et al., 2004 Seri
). The astroglial nature of some NSCs is not surprising since radial glial cells (RGCs), their embryonic counterparts, haveet al., 2001
recently been demonstrated to fulfill neurogenic and gliogenic functions during the forebrain development ( ; Anthony et al., 2004 Levitt
; ; ; ). During the postnatal stage, RG-derived cells progressivelyand Rakic, 1980 Malatesta et al., 2003 Noctor et al., 2001 Voigt, 1989
evolve into GFAP  cells. In contrast to those emigrating into parenchyma, those remaining in close proximity to the ventricular surface+
conserve their multipotent abilities and locally evolve into adult neurogenic cells ( ; ).Laywell et al., 2000 Merkle et al., 2004
The adult neurogenesis is mainly controlled by different cues present in the germinal microenvironment ( ; Garcion et al., 2001 Lim et
; ; ; ). This restricted environment might among others, also control theal., 2000 Liu et al., 2005 Machold et al., 2003 Tropepe et al., 1997
development of astrocytes, suggesting that multipotent GFAP-expressing cells in the adult forebrain refer to astrocytes in an immature but
unidentified developmental stage ( ; ; ; ).Bonaguidi et al., 2005 Garcia et al., 2004 Laywell et al., 2000 Steindler and Laywell, 2003
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A prerequisite step in categorizing immature cells within a continuum of differentiation includes finding specific molecular markers.
In the case of GFAP-expressing cells, the S100B calciprotein could be such a marker since its expression correlates with the
spatiotemporal maturation of the glial cells ( ; ; ). This hypothesis isCicero et al., 1972 Deloulme et al., 2004 Ghandour et al., 1981
strengthened by the recent observation that S100B is not expressed in the bipolar GFAP-expressing cells present in SGL and the SVZ of
adult mouse brain ( ; ; ). To determine whether the presence or the absence ofDeloulme et al., 2004 Filippov et al., 2003 Garcia et al., 2004
S100B in GFAP-expressing cells is relevant to their maturation status and their NSC attributs, we have examined the expression pattern of
S100B during the forebrain development. We show here, that S100B is a late marker of astrocyte development being expressed long after
GFAP and characterizing a mature stage. By taking advantage of -EGFP transgenic mice, we demonstrate that the onset of S100Bs100b
expression in astrocytes is associated with the loss of their potential to form neurospheres. We next show that the adult subventricular
environment and EGF repress S100B expression  while maintaining their neurosphere forming potential . Altogether, ourin vivo in vitro
findings suggest that the onset of S100B expression defines a critical period in which GFAP-expressing cells acquire a more mature
developmental stage and lose their neural stem cell potential.
Materials and Methods
Mice
-EGFP ( ) and -actin-GFP transgenic mice ( ) were housed under standard laboratorys100b Vives et al., 2003 β Okabe et al., 1997
conditions. C57/Bl6 mice were purchased from Charles River Laboratories (Arbresle, France). Experiments were performed according to
the principles of laboratory animal care in compliance with European and French law. Mouse embryos and newborn mice (E16-P15) were
anesthetized by hypothermia and killed by decapitation.
Primary astrocytic cultures
Hemispheres from whole forebrain of P2 newborns were separated, hippocampus, fimbria and septum were excluded and the
meningeal membrane was removed. Lateral ventricular zone and cortex were carefully dissected out and treated separately. Tissues were
dissociated by trypsinization and mechanical trituration in Hanks balanced saline solution containing 2.5 mg/ml trypsin (Invitrogen) and 1 
g/ml DNAse. Microglial cells were removed by preplating the cell suspension on non-coated Petri dishes for 15 min. The resulting cellμ
suspension was then replated on non-coated Falcon Petri dishes in DMEM medium supplemented with 10  FBS. After 4 days % in vitro
(DIV), oligodendrocyte progenitor cells and neuroblasts growing on top of the developing astroglial layer, were selectively removed by
flushing as previously described ( ). At DIV 15 and DIV 30, non-astrocytic cell contamination was evaluated usingDeloulme et al., 1990
O4 antibody, antibodies against PDGFR-  and MBP for oligodendroglial cells, -tubulin III for neuronal cells, fibronectin (DAKOα β
Cytomation) for fibroblastic cells and MOMA-2 monoclonal antibody (Chemicon) for macrophagic/monocytic cells. The percentage of
non-astrocytic cells never exceeded 2.5  of the cells.%
Immunohisto/cytochemistry
Cryostat brain tissue sections and cell preparations were fixed with 4  PFA as detailed previously ( ). The% Deloulme et al., 2004
following primary antibodies were used: mouse hybridoma supernatants RC2 and O4 (Developmental Studies Hybridoma Bank,
University of Iowa), rat monoclonal antibody (mAb) anti-GFAP (1:500, USB biological), rat mAb anti PDGFR-  (1:100, Pharmingen),α
mouse mAb anti-S100B (1:1500, ( ), mouse mAb anti- -tubulin III (1:1000, Berkley company), rabbit polyclonalTakahashi et al., 1999 β
antibodies (pAb) anti-human S100B (1:700, DAKO Cytomation), rabbit pAb anti-Olig 2 (1:1000), rabbit pAb anti-proteoglycan NG2
(1:200, Chemicon), guinea pig pAb anti-GLAST (1:8000, Chemicon). The specificity of anti-S100B antibodies was controlled on S100B /−
 brain sections as previously described ( ). All sections and cell preparations were permeabilized and blocked in TBS− Deloulme et al., 2004
containing 1 mM CaCl , 0.2  Triton X-100 and 5  normal goat serum (NGS) for 25 min. Embryonic tissue preparations were further2 % %
treated with Mouse-on-Mouse blocking IgG reagent as described by the manufacturer (VectorShield). Finally, the primary antibodies were
applied overnight at 4 C followed an incubation of 45 min with an appropriate secondary antibodies conjugated with cyanin3, cyanin5°
(Jackson immunoresearch Laboratories) or Alexa 488 (Molecular Probes Inc.). Nuclear counterstaining was performed with Hoechst
33258 (1 g/ml) or To-pro3 (2 M, Molecular Probes). Fluorescent images were obtained with a Zeiss fluorescent microscope (Axiovertμ μ
200M) or with a Leica (TCS SP2) confocal microscope.
Neurospheres from astrocytic cultures
7, 15 or 30 DIV primary astrocytic cultures from cortex and lateral ventricle SVZ were prepared as described above. Astrocytic cells
were dissociated by incubation at 37 C with cell dissociation reagent (Sigma, C5782) for 20 min at 37 C and then trypsin was added to a° °
final dilution of 1:100 (Gibco) for 2 min. Cells were gently triturated, pelletted for 5 min at 1000 rpm, resuspended in cell dissociation
reagent, filtered through a 40 m-mesh nylon cell strainer (Falcon). Dissociated cells were resuspended at a density of 5000 cells/ml inμ
DMEM/F12 (Invitrogen) supplemented with B-27 complement (1:50, Invitrogen) and 10 ng/ml each of human recombinant EGF
(Peprotech) and bFGF (our laboratory). Growth factors were added every second day. In this model, only astrocytic cells and
S100B is absent in SVZ GFAP expressing cells
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GFAP-expressing cells are able to generate primary neurospheres ( ; ). After 12 DIV, spheres wereImura et al., 2003 Laywell et al., 2000
plated on PLL-coated coverslips and either counted or induced to differentiate for 4 days by growth factor withdrawal and addition of N2
and B27 complements (1:100 and 1:200, respectively, Invitrogen) and 3  FBS.%
FACS Sorting
15 and 30 DIV primary astrocytic cultures obtained from the forebrain of P2 newborn -EGFP mice were prepared ands100b
dissociated as described above. Dissociated astrocytic cells were sorted using a MoFlo machine (Dako Cytomation). Electronic gates were
defined using wild-type and GFP-astrocytic cultures derived from GFP transgenic mice. EGFP-positive and negative cells sorted from 
-EGFP brain tissue were counted and resuspended in neurosphere medium. In some experiments, secondary astrocytic cultures weres100b
generated from sorted -EGFP negative cells. -EGFP negative cells were plated at high density (1.10  cells/cm2) on PLL-coateds100b s100b 5
coverslips and treated every second day with 10 ng/ml EGF.
Astrocytic cell transplantation
SVZ astrocytic cultures derived from -actin-GFP mice were dissociated at 15 DIV and then injected stereotaxically (1.104 cells/2 l)β μ
into the striatum or the SVZ of adult (8-week old) C57/Bl6 hosts at the following coordinates (mm) anteroposterior (AP), mediolateral
(ML) and dorsoventral (DV) relative to Bregma AP/ML/DV: 0.6/2/ 3 or 0.6/1.1/ 3 respectively. After 1 or 4 weeks, brains were removed− −
after intracardial perfusion of 4  PFA and stained as described above. In some experiments, grafted mice have been given an i.v. injection%
of EGF (400 ng/40 l PBS) every second day, for 4 weeks.μ
Western blot-analysis
The analysis of S100B, GFAP and -tubulin in astrocytic cell extracts was carried out using 11  SDS-Tris-Tricine polyacrylamideα %
gels as previously described ( ). The commercial secondary antibodies used in Western blot were conjugated withDeloulme et al., 2000
horseradish peroxidase and proteins were visualized using ECL kit (NEN).
Cell counts and statistics
For counting, astrocytic cells were plated in 4-well Permanox slides and treated as described above. Quantitative analyses were
performed by counting at least 500 cells per well. Two or 3 wells were counted for each combination of double or triple staining. The
number of independent culture is indicated in legends.
, the number of counted cells and the number of mice are indicated in figure legends. For each combination staining, theIn situ
counting was performed on 2 to 5 slice preparations using a confocal microscope.
In neurosphere experiments, astrocytic cells were resuspended at a density of 5000 cells/ml of DMEM in 35 mm Falcon Petri dishes
containing 2 ml culture medium supplemented as described above. After 12 DIV, neurospheres were sedimented, resuspended in 100 l ofμ
DMEM and plated in 96 well Falcon micro-plates. Neurospheres were photographed and spheres larger than 50 m were counted. Threeμ
dishes were plated for each point. The number of independent cultures is indicated in legends.
Statistical analysis of the raw data was performed by analysis of variance followed by Student s t test using Excel software. The values’
are considered as significant when p is <0.05.
Results
In this study, we designated astrocytes, cells that express the GFAP.
S100B expression characterizes a mature developmental stage of astrocytic lineage
During astrogliogenesis, RGCs progressively lose the nestin epitope recognized by the RC2 monoclonal antibody and acquire GFAP
staining and a stellate morphology. To determine when S100B expression appears during astrogliogenesis, we analyzed and quantified its
expression from after birth until adulthood in different zones of the telencephalon including the striatum, the cortex and the corpus
callosum ( ). At postnatal day 2 (P2), S100B is absent from RC2  transforming RGCs which begin to express GFAP in their thinFig. 1 +
radial processes ( ). As previously reported, ( ; ), most S100B  cells present at P2Fig. 1A and B Deloulme et al., 2004 Hachem et al., 2005 +
express the proteglycan NG2, the PDGF-  receptor and the Olig2 transcriptional factor and likely correspond to oligodendroglial cells (α
). At P8, the percentage of GFAP  cells expressing S100B varies between 10 to 30  depending on the region of thesupplemental figure 1 + %
telencephalon ( ). At this stage, differentiating astroglial cells harbor a more ramified morphology, a strong GFAPFig. 1C and H
immunostaining, and progressively lose their RC2  processes ( ). By P14, RC2 staining has totally disappeared (data not show) and+ Fig. 1D
the astrocytic morphological maturation is almost completed. More than 67  at P14, and virtually all highly ramified GFAP  cells in the% +
adult parenchyma, express the S100B protein ( ). The late acquisition of S100B by multipolar astrocytic cells of theFig 1E F and H–
S100B is absent in SVZ GFAP expressing cells
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forebrain, long after the gain of GFAP and loss of RC2 staining, is also evident on Western blots of brain extracts ( ). Together,Fig. 1G
these results indicate that in astrocytic cells, S100B expression characterizes a mature developmental stage.
GFAP-expressing cells never express S100B protein in adult germinal zones
In contrast to parenchymal astrocytes, we found that astrocytes of the germinal zones do not express S100B. This is true from the onset
of postnatal development ( ) until adulthood ( ), whereas the level of S100B expression progressively increases withFig 2A C– Fig. 2D and E
time in ependymocytes ( ). Because of their bipolar morphology, the lack of S100B coexpression in GFAP  astrocytes ofFig 2B and C +
adult germinal zones could be interpreted as these cells being locked in an immature developmental stage. However, one could not exclude
the possibility that these GFAP-expressing cells constitute a specific subpopulation of cells unable to express S100B.
Subventricular GFAP-expressing cells have the potential to mature into S100B  astrocytes + in vitro
To test whether the S100B expression onset correlates with terminal development of GFAP-expressing cells or whether GFAP  cells+
of SVZ constitute a specific subpopulation of astrocytic cells that are intrinsically unable to express S100B, we investigated their behavior
in culture. To this end, we compared the pattern of S100B and other astroglial markers in astrocytic monolayer cultures derived from the
cortex or the lateral ventricular wall of P2 mice. After 7 days in culture (DIV 7), the persistence of immature astroglial characteristics in
SVZ astrocytes was evidenced by the high expression of embryonic or astroglial progenitor markers such as RC2 ( ), vimentin,Fig. 3A
GLAST or nestin (data not shown). The same was found with whole cortex-derived cultures (data not shown). At this stage, only 20  of%
GFAP  cells express S100B ( ). Then, a phenotypical transition occurs in both types of culture that is accompanied by a progressive+ Fig 3C
and drastic down regulation of RC2 ( ) and nestin expression (data not shown), the persistence of GLAST expression (dataFig. 3B and E
not shown) and the generalization of GFAP and S100B expression between DIV 15 and DIV 30 ( ). At 30 DIV, more than 90Fig. 3D and E
 of GFAP-expressing cells express S100B ( ). There is no significant difference in the percentages of S100B , GFAP  or RC2% Fig. 3D + + +
cells in astrocytic cultures derived from the SVZ or the entire cortex after 30 DIV ( ). The time course of GFAP and S100BFig. 3E
expression analyzed by Western blot confirmed that S100B is detected later than GFAP in crude protein extracts of astrocytic cultures (
).Fig. 3F
These results first indicate that the succession of the various astrocytic developmental stages observed  recapitulates that seen in vitro
. S100B appears in GFAP-expressing cells and its onset of expression correlates with terminal astrocytic developmental stage.in vivo
Second, these results indicate that, provided they are removed from their original SVZ microenvironment, perinatal SVZ astrocytic cells
can complete the same program of differentiation along the astroglial lineage as their parenchymal counterparts.
S100B  astrocytic cells are multipotent whereas S100B  astrocytes are unipotent− +
To determine whether the S100B expression onset correlates with the lost of their NSC potential, we took advantage of transgenic
mice expressing EGFP under the control of the  promoter ( ). Since S100B expression in brain was not restricted tos100b Vives et al., 2003
astrocytic lineage ( ; ) and ), we generated primary cortical astrocytic culturesDeloulme et al., 2004 Vives et al., 2003 supplemental Figure 1
from P2 -EGFP newborn mice. As expected, the number of EGFP  cells increased with time spent in culture ( ). We thens100b + Fig. 4A
ensured that variations in the level of EGFP expression faithfully reflected variations in the level of the endogenous S100B protein. At 15
and 30 DIV, approximately 15  and 60  of the cells (15 6 and 57  8, n 2 independent cultures) expressed EGFP respectively, and% % %± %± =
virtually all EGFP  cells expressed endogenous S100B ( ). We then sorted EGFP  from EGFP  astrocytic cells by flow cytometry+ Fig. 4B − +
after 15 or 30 DIV and tested their capacity to form multipotent self-renewing neurospheres . As expected, both cell populationsin vitro
were GLAST  and GFAP  ( ) and most of EGFP  sorted cells expressed RC2 ( ). When placed in neurosphere culture+ + Fig. 4D and E − Fig. 4C
conditions, EGFP  astrocytic cells generated numerous spheres devoid of EGFP expression ( ) and capable of generating− Fig. 4G G1–
secondary self-renewing neurospheres (data not shown). In differentiating medium, neurospheres from EGFP  astrocytes generated O4− +
oligodendroglial cells, -tubulin III  neuroblasts and GFAP  astrocytic cells, attesting to their  multipotentiality ( ). Inβ + + in vitro Fig. 4I, J
contrast to EGFP  cells, EGFP  sorted cells generated only a few, small EGFP  spheres ( ), with no self-renewal potential− + + Fig. 4H H1–
(data not shown). Most of these spheres were unipotent and gave rise only to GFAP  astrocytes under differentiating conditions ( ).+ Fig. 4K
Interestingly, an equivalent amount of neurospheres was generated from EGFP  cells derived from either 15 or 30 DIV cultures ( ).− Fig. 4F
This indicates that old  cultured astrocytes have the same differentiation potential as young  astrocytes provided that they are in a“ ” “ ”
S100Bimmature state. The converse is true with EGFP  mature astrocytes lacking the ability to generate multipotent neurospheres+
regardless of the time spent in culture ( ). Interestingly, after 4 days spent in differentiating medium, neurospheres derived fromFig. 4F
EGFP  astrocytic cells gave rise to EGFP /GFAP  astrocytes and EGFP /O4  oligodendrocyte progenitors ( ). Furthermore,− + + + + Fig. 4I and J
when sorted EGFP  cells were grown straight away in astroglial differentiating medium, the level of EGFP expression progressively−
increased with time (compare  to ). These results obtained  confirm that EGFP  cells are genuine astrocytes capableFig. 6A Fig. 6C in vitro −
of progressing toward a higher level of maturation. In addition, EGFP  derived neurospheres gave rise to cells that continuously expressed+
S100B is absent in SVZ GFAP expressing cells
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EGFP in the presence of EGF/bFGF, even after 12 DIV ( ). This strongly suggests that the growth factors, at least in ourFig. 4H H1–
paradigm, cannot induce the down-regulation of S100B expression nor  acquisition of a multipotent stem/progenitor cell fate byde novo
mature astrocytes in culture. Taken together, these results show that the onset of S100B expression defines a critical period after which the
multipotent state of murine astrocytic cells is irreversibly lost.
The adult SVZ microenvironment represses the S100B expression in transplanted astrocytic cells
To determine the role of microenvironmental cues in controlling the expression of S100B , primary astrocytic cells obtainedin vivo
from the SVZ of -actin-GFP mice ( ) were grafted into the adult striatum or the SVZ of C57/BL6 hosts after 15 DIV (β Okabe et al., 1997
). One week after striatal grafting, 17  (SD 6 , n 2 mice) of GFP /GFAP  cells expressed S100B ( ). This valueFig. 5A B– % ± % = + + Fig. 5A A1–
increased to 87  (SD 9.5 , n 4 mice) three weeks later ( ). In addition, many of these astrocytes were highly ramified,% ± % = Fig. 5A A1–
completely integrated into the host brain and contacted blood vessels, confirming the functional maturation of these cells (supplemental
). Furthermore, 3 weeks after transplantation into the striatum, FACS sorted s100b-EGFP  became EGFP  and contacted bloodFigure 5 − +
vessel (data not shown). In contrast, when -actin-GFP astrocytic cells were orthotopically grafted into the SVZ, only 30  of GFAP /GFPβ % +
 cells (28 11 , n 3 mice, p<0.0005) became S100B  4 weeks after implantation ( ) and they were mainly localized in the+ ± % = + Fig. 5C C1–
striatal part of the graft ( , arrowheads).Fig. 5C1
Together, these observations confirm that SVZ astrocytic cells have the potential to mature towards fully differentiated S100B+
astrocytes. They also clearly demonstrate the major role played by the adult SVZ microenvironment in preventing the onset of S100B
expression and differentiation along the astrocyte lineage.
EGF blocks the S100B expression in GFAP-expressing cells and enhances their multipotent abilities in vitro
Many reports have shown that the EGF receptor (EGF-R) signaling pathway, activated by EGF and/or TGF- , stimulates astrocyteα
development  and  ( ; ; ). We therefore wondered whether EGFin vitro in vivo Burrows et al., 1997 Kornblum et al., 1998 Sibilia et al., 1998
could be part of the microenvironemental factors acting on S100B expression and astrocyte development. To this end, we first generated,
from the SVZ of -EGFP mice, 15 DIV astrocytic primary cultures. Then EGFP  cells were sorted by flow cytometry, and platted ats100b −
high density in astrocytic secondary culture medium. After 8 and 15 DIV in the absence or presence of EGF, we analyzed and quantified
the respective proportions of RC2, GFAP and EGFP positive cells ( ). As expected, culturing the cells in the absence of EGF forFig. 6A E–
8 15 days substantially increased the proportion of mature RC2 /GFAP /EGFP  (11 2  and 42 5 , respectively, n 3 independent– − + + ± % ± % =
cultures) and this was done mainly at the expense of immature RC2  populations (i.e. RC2 /GFAP /EGFP  and RC2 /GFAP /EFGP+ + − − + + −
cells) ( ). In contrast, in the presence of EGF, only few RC2 /GFAP /EGFP  cells could be detected after 8 and 15 DIV (4.6 0.9Fig. 6E − + + ± %
and 5.6 1.1 respectively, n 4 independent cultures), whereas the RC2 /GFAP /EGFP  population was drastically expanded after 8 and 15± = − + −
days of treatment ( ). This expansion was done at the expense of RC2  populations which nearly disappeared at 15 DIV (3,8 1 , nFig. 6E + ± %
 4) ( ). It is important to note that the repression of S100B expression is reversible. Indeed, and in agreement with our= Fig. 6B and C
neurospheres differentiation data ( ), EGF withdrawal induces a progressive expression of EGFP in GFAP expressing cellsFig. 4I and J
(data not show). Together, these results show the dual effect of EGF signaling on the maturation of astrocytic cells. It favors the RC2+
/GFAP  to RC2 /GFAP  transition, but it also blocks the progression to the mature GFAP /S100B  stage.− − + + +
We next asked whether the arrest of astrocytic cells in a RC2 /GFAP /EGFP  stage by EGF influence their neurosphere− + −
neurosphere-forming capacity. We compared the percentages of multipotent neurosphere-forming cells immediately following the sorting,
or after 15 days of culture in medium supplemented or not with EGF ( ). Immediately after sorting, 3.7  of EGFP  cells generatedFig. 6F % −
multipotent neurospheres NSs (373 38 NSs per 10  cells). The neurosphere-forming capacity dropped by 50  when sorted EGFP  cells± 4 % −
were cultured for 15 days in the absence of EGF (166 47 NSs per 10  cells, P<0,005). By contrast, after 15 days of EGF pretreatment the± 4
neurosphere-forming capacity was tripled (1005 131 NSs per 10  cells, P<0.0005). Hence, it appears that a chronic treatment of astrocytic± 4
cells by EGF stimulates the progression from the RC2 /GFAP  to the RC2 /GFAP  stage, but arrests GFAP-expressing cells in an S100B+ − − +
 immature stage. In addition to maintaining cells in an immature state, the 15 DIV pretreatment with EGF also strongly increases the−
multipotent neurosphere-forming capacity of sorted EGFP  astrocytic cells.−
Circulating EGF had previously been shown to pass easily through the blood brain barrier and to diffuse into the host brain (Pan and
). We then wondered if EGF could modulate S100B expression and astrocyte maturation . Astrocytic cells grown inKastin, 1999 in vivo
secondary culture obtain from -actin-GFP mouse brain were grafted into the striatum. After 4 weeks, 87  (SD 9.5 , n 4, p<0,0005) ofβ % ± % =
GFP /GFAP  cells expressed S100B (  and ). EGF treatment reduced the amount of S100B  cells to 12  (SD 8 , n+ + Fig. 4B B1– Fig. 6H + % ± % =
3) ( ). This indicates, that as , EGF has the potential to prevent the evolution of astrocytic cells to an S100B-expressingFig. 6G H– in vitro
stage . Taken together, these results suggest that EGF is a microenvironmental factor which maintains the SVZ GFAP-expressingin vivo
cells into the immature S100B-developmental stage.
S100B is absent in SVZ GFAP expressing cells
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Discussion
The aim of the present study was to determine whether the heterogeneity of S100B expression within the GFAP expressing population
might be related to their developmental status and their NSC potential. Our results can be summarized as follows. First, the onset of S100B
expression in GFAP expressing astrocytic cells defines a terminal developmental stage  and . Second, cultured astrocyticin vivo in vitro
cells lose their NSC abilities when they express S100B. Third, expression of S100B in transplanted astrocytic cells is controlled by adult
microenvironmental cues. Forth, chronic exposure to EGF maintains astrocytic cells in a S100B  immature state, both  and .− in vitro in vivo
Our data collectively support the idea that in adult germinal zones of the mammalian brain, GFAP-expressing astrocytes are maintained in
an immature S100B  developmental stage through the action of microenvironmental cues.−
In the developing mouse brain, S100B expression defines a new mature developmental stage and discriminates astrocytes present
in adult germinal zones from parenchymal astrocytes
During neocortical gliogenesis, astrocytic cells derived from RC2  radial glia progressively lose their elongated aspect to become+
highly ramified GFAP  astrocytes. The acquisition of GFAP together with a complex morphology has led researchers in the field to+
consider all GFAP-expressing cells as mature astrocytes. However, this view has recently been challenged by the discovery that some
GFAP  cells located in adult germinal zones are neural stem cells ( ; ; ; + Doetsch et al., 1999 Garcia et al., 2004 Laywell et al., 2000 Seri et
) displaying features of fully differentiated astrocytes like GFAP expression, and immature characteristics like bipolarity (al., 2001 Garcia
). In this study, we show that unlike GFAP immunochemistry which does not allow to clearly determine the number ofet al., 2004
processes of a given cell, and thus its maturation state, S100B reliably defines a late stage of GFAP  cell maturation. Based on the+
combined use of S100B, GFAP and RC2, one can thus distinguish three successive stages of murine astrocytic development ( ). TheFig. 7
RC2 /GFAP  stage (Stage I) coincides with the beginning of astrogliogenesis near the wall of the lateral ventricle and in the neocortex.+ +
The second stage (Stage II) correlates with the lost of RC2 staining in transforming RGCs. Finally, the third stage (Stage III) corresponds
to the onset of S100B expression in neocortical GFAP  astrocytes. This stage correlates with their terminal morphological maturation and+
defines the more mature state of the neocortical astrocytes  as well as . However, one should be aware that thisin vivo in vitro
characterization might not hold true for every species. Indeed, our preliminary results showed that the spatiotemporal pattern of forebrain
S100B expression differs between mouse and rat forebrains in both the astrocytic and oligodendroglial lineages (ER and JCD, unpublished
data). In agreement with a recent report describing the post-natal development of rat and mouse SVZ ( ), we found thatPeretto et al., 2005
the onset of S100B expression occurs before the onset of GFAP expression in the astrocytic lineage of rat telencephalon (our unpublished
results). Therefore, in adult and developing rat brain, S100B does not discriminate immature from mature GFAP-expressing cells and
might explain the presence of S100B in GFAP-expressing cell of adult rat germinal zones ( ) and our unpublished data).Namba et al., 2005
In the adult mouse germinal zones, GFAP  cells are S100B . These cells have the potential to become S100B  when cultured. This is+ − +
in agreement with previous studies suggesting that germinal GFAP  cells belong to the astroglial lineage. Moreover, it strongly suggests+
that the main differences (functional and phenotypical) between germinal zone and parenchymal astrocytes relate to their developmental
stages rather than to their belonging to different astrocytic subtypes. However, we cannot exclude the existence  of a subpopulationin vivo
of GFAP-expressing cells harboring multiple differentiation traits except S100B expression.
Astrocytic S100B expression and neural stem cell potentials
The results of our  investigations support a recent model proposing that the degree of maturation of germinal zone astrocytes isin vitro
lower than that of their parenchymal counterparts ( ; ; ). Astrocytic culturesBonaguidi et al., 2005 Garcia et al., 2004 Laywell et al., 2000
neonatally derived from the SVZ or the neocortex conserve their stem/progenitor cell potential as long as they remain S100B , and lose it−
when they are S100B  ( ). Furthermore, the expression pattern of S100B in developing neocortical astrocytic lineage ( )+ Fig. 4 Fig. 1
coincides with the loss of their multipotentiality which occurs during the second postnatal week ( ).Laywell et al., 2000
Although we have demonstrated that the multipotentiality is lost when astrocytes reach the S100B  stage III, our results do not allow+
us to assign a specific pattern of molecular markers stage to multipotent astrocytes. It is important to note that the time spent in culture
does not impact on the percentage of multipotent neurospheres generated from EGFP /S100B  sorted cells ( ). This percentage,− − Fig. 4
ranging between 2.5 to 4 , is low and similar to that reported previously ( ; ). Altogether, these% Garcia et al., 2004 Laywell et al., 2000
observations suggest that remaining in an immature S100B  state is a  condition for GFAP-expressing cells to fulfill their− sine qua non
stem/progenitor cell function.
Nevertheless, in  knock-out mice ( ), we were unable to observe morphological or functional differencess100b Xiong et al., 2000
between SVZ and parenchymal astrocytes (ER and JCD, unpublished data). This suggests that S100B may not control stem/progenitor
attributes of GFAP expressing cells. However, we and others have shown that S100B can form heterodimers with S100A1 and S100A6,
two isoformes expressed in GFAP-expressing cells of the SVZ ( ; ; ).Deloulme et al., 2000 Yamashita et al., 1997 Yang et al., 1999
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Therefore, functional redundancy or compensatory mechanisms might explain the lack of obvious phenotype in GFAP expressing cells of 
 null mice.s100b
Environmental cues and astrocytic development
Adult SVZ astrocytes reside in a particular and complex microenvironment called niche  which regulates inherent NSC features (“ ”
; ). Vasculogenesis, multiple diffusible signaling factors (TGF , BMP2, Noggin, GABA, Shh),Doetsch, 2003 Spradling et al., 2001 α
components of the extracellular matrix (Tenacin-C) are some of the actors present in these niches  and implicated in self-renewal and“ ”
differentiation of adult NSCs ( ; ; ; ). We have shown that, whereasGarcion et al., 2001 Lim et al., 2000 Liu et al., 2005 Tropepe et al., 1997
cultured SVZ astrocytes have the potential to mature into S100B  cells, they are arrested at developmental stage II  (i.e. RC2+ in vivo −
/GFAP /S100B ) ( ). Furthermore, grafting experiments show that in contrast to the parenchyma that allows maturation of S100B+ − Fig. 5 −
into S100B  astrocytes, the SVZ environment prevents it. We have shown that EGF treatment blocks astrocytes at stage II and increases+
their capacity to generate multipotent neurospheres in culture. When injected , EGF also prevents the onset of S100B expression inin vivo
grafted -actin-GFP and -EGFP astrocytic cells (  and data not shown).β s100b Fig. 6
The physiological relevance of these results is validated by the fact that in the adult SVZ, the EGF-R is expressed in dividing
progenitors as well as in some astrocytes ( ) and EGF-R signaling has been implicated in astrocytic development and inDoetsch et al., 2002
the control of adult neurogenesis ( ; ; ). Although exogenously added EGF actsBurrows et al., 1997 Kornblum et al., 1998 Sibilia et al., 1998
to maintain astrocytes in a relatively immature state, it probably is not the sole factor implicated in this process  (in vivo Bonaguidi et al.,
). we can however propose that EGF-R signaling is a key element of the SVZ niches allowing GFAP-expressing cells to remain in2005
developmental stage II which is a necessary condition for the adequate functioning of this germinal zone.
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Figure 1
S100B is expressed long after the gain of GFAP and the loss of RC2 and characterizes a mature developmental stage of the astrocytic lineage. 
, coronal sections of developing post-natal telencephalon of mice at P2, P8, P14 and P60 were subjected to double immunolabeling asA E–
indicated. , at P2, RC2  transforming RGCs do not yet express S100B (A, arrowheads) but start to express GFAP in their radial processesA B– +
(B, arrows). In B, arrowheads point to RC2  RGC bodies which are still negative for GFAP staining. , at P7, RG transforming cells are+ C D–
more stellate and express GFAP in their cell bodies (C and D, arrowheads). Some of these cells start to express S100B (C, arrow). In D,
arrows point to a radial process with residual RC2 staining. E, at P14, most of GFAP expressing cells express S100B (arrows). The arrow
points to a GFAP  cell that does not yet express S100B. , at P60, all GFAP  cells express S100B (arrows). In A, C, E and F, asterisks+ F +
indicate S100B expressing cells that do not express RC2 or GFAP. These cells likely are oligodendroglial cells as indicated in supplemental
. , Western blot analysis of GFAP and S100B expression during the forebrain postnatal development. -tubulin ( Tub) was used asfigure 1 G α α
loading control. , quantitative analysis of GFAP  cells expressing S100B in different telencephal regions including the cortex, the corpusH +
callosum ( ) and the striatum during postnatal development. 3 mice were analyzed at P8 and P14 and 5 at P60. Errors are  SD.  p<0.001, CC ± **
 p<0,05. Scale bars: 20 m.* μ
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Figure 2
S100B expression pattern in developing and adult germinal zones A E, coronal sections of developing and adult SVZ (A C and E) and adult– –
hippocampus (D) were subjected to double immunolabeling as indicated. , at P8, RC2  RG transforming cells express GFAP in radialA +
processes. , cell bodies (arrowhead) and radial process (arrows) of transforming astrocytic cells at P7 (B) and P14 (C) express GFAP butB C–
are devoid of S100B staining. In developing SVZ, S100B is expressed in ependymocytes (asterisks). , in adult dentate gyrus, radial GFAPD +
cells of the subgranular layer never express S100B (arrowheads). Arrows point to stellate GFAP /S100B  cells. , in adult SVZ, S100B+ + E
expression is restricted to ependymal cells. The subependymal GFAP  cells with bipolar morphology are devoid of S100B staining+
(arrowheads). lv, lateral ventricle; St, striatum; gl, granular layer. Scale bars: 20 m.μ
Figure 3
Cultured subventricular and cortical astrocytes mature into S100B  cells. Astrocytic cultures derived from the SVZ (A D) and the neocortex+ –
(not shown) of newborn mice were immunolabeled at 7, 15 and 30 DIV as indicated. The percentages of RC2 , GFAP  and S100B  cells in+ + +
the SVZ and the cortical cultures are represented in E. Western blot analysis of GFAP and S100B expression during astrocytic development in
culture is presented in F. -tubulin ( Tub) was used as loading control. Each bar represents the average of 2 to 4 independent cultures. Errorsα α
are  SD. DIV, days . Scale bars: 20 m.± in vitro μ
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Figure 4
In astrocytes, activation of  gene is linked to the loss of NSC potential. A and B, cultured astrocytic cells were obtained from wholes100b
forebrains of newborn transgenic -EGFP mice and were characterized at 7, 15 and 30 DIV as indicated. , EGFP expressions100b A A2–
increases with the time spent in culture. , at 30 DIV, nearly all EGFP  cells express both endogenous S100B and GFAP. , EGFP  andB + C E– +
EGFP  cells derived from 15 and 30 DIV cultures were sorted by FACS and double immunolabeled as indicated. Most sorted EGFP  cells− −
are in a RC2 /GFAP  or a RC2 /GFAP  developmental stage, all of them express GLAST cells (C,E), while EGFP  cells are GFAP+ − + + + +
/GLAST  cells (D). , unlike sorted EGFP  cells, most sorted EGFP  cells are unable to generate neurospheres (NSs) with a size higher+ F H– − +
than 50 m (H). EGFP expression is maintained in small NSs derived from sorted EGFP  cells even after 12 days of EGF/bFGF treatmentμ +
(H1). In F, each bar represents the average of 4 independent cultures, each counted in triplicate. Errors are  SD. , NSs derived from± I K–
EGFP  cells are multipotent and give rise to -tubulin III  neuroblasts (I), O4  oligodendroglial cells (J) and GFAP  astrocytic cells (I and J),− β + + +
whereas the small NSs derived from sorted EGFP  cells are mostly unipotent and give rise to GFAP  astrocytes (K). A and G, Zeiss+ +
conventional microscopy. B F and H J, stack of 5 to 8 optical sections captured with Leica confocal microscope. Scale bars: 20 m in A E– – μ –
and H J; 100 m in G.– μ
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Figure 5
Maturation of grafted astrocytic cells is controlled by micro-environmental factors. , 15 DIV cultured astrocytic cells derived fromA C–
transgenic newborn mice expressing GFP under the ubiquitous -actin promoter were grafted stereotaxically in the striatum (A A1, B B1) orβ – –
in the SVZ (C C1) of adult mice as indicated in D. GFP  cells grafted in the striatum progressively expressed S100B after 1 and 4 weeks (A– + –
A1 and B B1 respectively) whereas most of GFAP /GFP  cells grafted in SVZ were maintained in S100B  immature state even after 4– + + −
weeks (C C1). Arrows and arrowheads point to GFP /GFAP /S100B  and GFP /GFAP /S100B  respectively. , Quantitative analysis of– + + + + + − E
GFP /GAFP  expressing S100B. At least 400 GFP /GFAP  cells were counted and n is the number of transplanted mice. Errors are  SD. lv,+ + + + ±
lateral ventricle; St, striatum, WPG, Week Post Grafting. Scale bars are 50 m in A, B and C and 20 m in A1, B1 and C1.μ μ
Figure 6
EGF prevents the activation of the  gene and maintains astrocytic cells in S100B  immature state  and . , sorted s100b − in vitro in vivo A D–
-EGFP  cells (EGFP ) from 15 DIV primary astrocytic cultures were replated in medium with serum in the absence ( EGF) or in thes100b − − −
presence of EGF ( EGF), and double-immununolabeled for the presence of RC2 and GFAP at 8 DIV and 15 DIV as indicated. EGF treatment+
stimulated the transition from RC2 /GFAP /EGFP  and RC2 /GFAP /EGFP  stages to RC2 /GFAP /EGFP  stage and maintained the+ − − + + − − + −
cells in this stage (C D). , percentages of different cell populations. , EGF treatment increases the number of NSs generated from cultured– E F
astrocytic cells after 15 DIV. NSs are generated from 15 DIV secondary astrocytic culture in the absence ( EGF) or in the presence of EGF (− +
EGF) and from sorted -EGFP  cells (Ctl) derived from 15 DIV primary culture. Each bar represents the average of 3 independents100b −
cultures, each counted in triplicate. Errors are  SD, Scale bars are 50 m in A and C and 20 m in B and D. , 15 DIV cultured± μ μ G G1–
astrocytic cells derived from transgenic newborn mice expressing GFP under the ubiquitous -actin promoter were grafted stereotaxically inβ
the striatum of adult mice as described in . Multiple i.v. injections of EGF (400 ng/40 l every second day for 4 weeks) prevent thefigure 4 μ
expression of S100B in GFP /GFAP  grafted cells compared to control mice (see ). , Quantitative analysis of GFP /GAFP+ + fig. 4B B1– H + +
cells expressing S100B. At least 400 GFP /GFAP  cells were counted and n the number of transplanted mice. Errors are  SD. Scale bars: 50 + + ±
m in G and 20 m in G1.μ μ
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Figure 7
Model of GFAP  astrocytic development. The onset of GFAP expression in parallel with the progressive down-regulation of RC2+
characterizes the stage I and the stage II respectively. Next, GFAP  astrocytes continue their developmental program and the onset of S100B+
expression defines the stage III. This stage includes restricted astrocyte precursors and terminally differentiated astrocytes. EGF signaling
exerts a double effect on GFAP  astrocytic development. It activates the transition from stage I to the stage II and blocks the transition from+
stage II to stage III.
